Press Releases

Title
Date
Statement
15-09-2017

IntraBio Inc. is pleased to announce significant progress in the treatment of rare and neurodegenerative diseases...

01-06-2017

IntraBio Ltd, a clinical stage biopharmacuetical company developing treatments for rare lysosomal storage disorders and neurodegenerative diseases...

01-04-2016

IntraBio Ltd has announced that it has been granted orphan designation (EU/3/17/1848) by the European Commission on its amino acid analogue-based drug product (IB 1000)...